Broad-spectrum coverage (aerobes, anaerobes, atypicals such as rickettsiae, chlamydiae, mycoplasmas): Which antibiotic best fits this profile?

Introduction / Context: Some pathogens lack classic peptidoglycan or live intracellularly (rickettsiae, chlamydiae, mycoplasmas). Tetracyclines are noted for wide coverage including many Gram-positive and Gram-negative bacteria, atypicals, and some anaerobes, making them a hallmark broad-spectrum class.

Given Data / Assumptions:

• We seek an agent covering aerobic/anaerobic bacteria plus atypicals (rickettsiae, chlamydiae, mycoplasmas).
• Standard pharmacology profiles are assumed.

Concept / Approach: Tetracyclines bind the 30S ribosomal subunit and block aminoacyl-tRNA binding, inhibiting protein synthesis. Their intracellular penetration underlies activity against rickettsiae and chlamydiae; activity against mycoplasma reflects ribosomal targeting in the absence of cell walls.

Step-by-Step Solution: Evaluate candidates: gentamicin (limited anaerobe/atypical coverage); metronidazole (excellent anaerobes/protozoa but weak for aerobes and atypicals listed); vancomycin (Gram-positive only); penicillin G (narrow spectrum). Identify tetracycline as classically covering rickettsiae, chlamydiae, mycoplasmas, and many aerobes; some anaerobic coverage exists depending on agent. Choose tetracycline as best match.

Verification / Alternative check: Clinical indications such as atypical pneumonia (mycoplasma, chlamydophila), rickettsial diseases (doxycycline), and broad empiric use support this selection.

Why Other Options Are Wrong: They lack the simultaneous atypical breadth or anaerobic/aerobic balance described.

Common Pitfalls: Overestimating aminoglycoside coverage of anaerobes (ineffective in low oxygen); assuming metronidazole is broad for all categories (it is not).

Final Answer: Tetracycline.